Bioprinting: An Organic Solution | SGInnovate
July 13 2021


Online Event

Bioprinting: An Organic Solution

Presented by SGInnovate and CATALYST
Partnered with Netherlands Embassy in Singapore

Bioprinting is a process that is similar to 3D printing, with the key difference being the material used to print the product. Instead of utilising plastic or synthetic material, bioprinting creates organic matter using “bio-ink”, usually a mixture of cell types collected from a patient. Although this might at first sound like an overly futuristic process, bioprinting is, in reality, a rapidly advancing technology that scientists hope to advance to clinical trials within the next five to ten years. 

Our panellists will shed light on the potential for bioprinting to become the latest ground-breaking solution in Bioengineering in this session. Learn more about how bioprinting is set to revolutionise the healthcare industry and the opportunities that arise out of this up and coming market.

Date:  13 July 2021, Tuesday
Time:  4:00pm – 5:00pm (Singapore Time / UTC +8)

4:00pm – 4:05pm: Welcome Remarks by SGInnovate and CATALYST
4:05pm – 4:25pm: Keynote Presentations by

  • Dr Riccardo Levato, Associate Professor, University Medical Center Utrecht

  • Dr Javier Fernandez, Assistant Professor, Singapore University of Technology and Design

4:25pm – 5:00pm: Panel Discussion and Q&A on Bioprinting: An Organic Solution with

  • Dr Riccardo Levato, Associate Professor, University Medical Center Utrecht

  • Dr Javier Fernandez, Assistant Professor, Singapore University of Technology and Design

  • Moderator: Dr Sowjanya Kallakuri, Vice President, Biotech Connection Singapore

Speakers' Profiles:
Dr Riccardo Levato, Associate Professor, University Medical Center Utrecht

Dr Riccardo Levato is currently Associate Professor of Translational Bioengineering and Biomaterials at the Department of Clinical Sciences (Faculty of Veterinary Medicine, Utrecht University) and a Principal Investigator at Regenerative Medicine Center Utrecht and the Department of Orthopedics of the University Medical Center Utrecht. His research interests focus on developing novel biofabrication strategies and cell-instructive biomaterials to create bioprinted, lab-made tissue models and transplantable engineered grafts, particularly for the regeneration of the musculoskeletal system. These efforts in integrating expertise in engineering, materials science and stem cell biology aim to understand and mimic the multifaceted architectural and biochemical structure of living tissues to develop effective treatments for human and veterinary healthcare.

In 2020, Riccardo was awarded a Starting Grant from the European Research Council to develop a novel volumetric bioprinting technology for organoid research and engineer functional bone marrow analogues in vitro. In addition, since 2021, he is the coordinator of a European consortium (ENLIGHT), funded under the Future and Emerging Technologies scheme (European Innovation Council pilot), aiming at developing biofabricated pancreas units to study treatments for diabetes.

To date, Riccardo has published 50 peer-reviewed articles in international journals (H-index=21), co-authored two book chapters and two patent applications, and secured more than 13 million Euros in research funds for his group and related consortia. In total, he has been (co-)supervisor of 13 PhD students (four completed, nine ongoings). He was conferred several awards for his work, including an Orthoregeneration Network Fellowship by the International Cartilage Repair Society (ICRS), the Wake Forest Institute for Regenerative Medicine Young Investigator Award, multiple presentations and travel awards, and the Julia Polak doctoral award from the European Society for Biomaterials. Riccardo is an active member of the ESB, TERMIS, ICRS, and he is serving on the Board of Directors of the International Society for Biofabrication. Before moving to Utrecht, he worked and received training in several research groups working in the fields of Biomaterials, Regenerative Medicine and Biofabrication: 3Bs, University of Minho (Portugal); BioMatLab, Technical University of Milan (Italy), the Biomaterials for Regenerative Therapies group at the Institute for Bioengineering of Catalonia (IBEC, Spain), and he holds a cum laude PhD in Biomedical Engineering from IBEC and the Technical University of Catalonia (Barcelona, Spain).

Dr Javier Fernandez, Assistant Professor, Singapore University of Technology and Design

Dr Javier Fernandez’s research at the Singapore University of Technology and Design (SUTD) is focused on the broad study, development, and application of biological materials in science and technology. In 2014, he was awarded the world’s most outstanding young researcher in materials science by the Bayer Foundation. Javier was also awarded the Zwick Science Award for his studies on Mechanical Testing and best PhD thesis at the University of Barcelona for studies in biopolymers in Microelectronics and Biomedicine.

After his PhD, Javier moved to the Massachusetts Institute of Technology (MIT), where he developed the “Micro-Masonry”, a technology to assemble artificial organs that was recognised as a “breakthrough in tissue engineering” (CNET). Later, he moved to the Wyss Institute at Harvard University, where he designed and made “Shrilk“, a compostable and biocompatible material inspired by the insect cuticle. Shrilk is referred, for example, to as “one of the materials that will change the future of manufacturing” (Scientific American), a “Supermaterial” (National Geographic), and has been chosen (with graphene) as one of the “five materials that could change the world” (The Guardian).

Javier regularly collaborates with some of the most important international media outlets. His opinions and views on scientific issues and environmental policies have been, for example, covered in personal interviews, documentaries, and articles of National Geographic, BBC, PBS, FOX, Euronews, Discovery Channel, The Guardian, Huffington Post, Scientific American.

Moderator's Profile:
Dr Sowjanya Kallakuri, Vice President, Biotech Connection Singapore

Dr Sowjanya Kallakuri is a developmental geneticist by profession. She graduated from India with a Bachelor in Genetics and a Master in Molecular and Human Genetics. She then received her PhD from the German Cancer Research Centre, Heidelberg in Developmental Genetics. She is currently responsible for end to end management of Medical and Scientific Projects at Neovation Consultancy Services and serves as Vice President of Biotech Connection Singapore (BCS). During her doctoral, post-doctoral and undergrad studies, Sowjanya was actively involved in organising several scientific events and retreats. Additionally, she has a flair for managing cultural events too. Through BCS, she wishes to continue her passion for Scientific outreach and education and contribute positively to BioTech entrepreneurship.

Topics: MedTech / HealthTech / BioTech

Industry: Health and BioMedical Sciences